Search
Ascentage Pharma: First-Half Revenue Declines 71.6% YoY to RMB 234 Million
2025-08-21 /
Read about 0 minute
Author：小编
Ascentage Pharma's revenue for the first half of 2025 plummeted to RMB 234 million, marking a significant year-over-year decrease of 71.6%. This decline was predominantly attributed to a reduction in intellectual property income. During the same period, the company sustained a net loss of RMB 591 million, in stark contrast to the RMB 163 million profit recorded in the corresponding period of the previous year.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
